Morgan
Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
About Morgan
Morgan is recorded as Analyst at Goldman Sachs. Morgan has spoken on 2 earnings calls across 1 company, most recently for Krystal Biotech, Inc. on November 3, 2025. The companies whose calls Morgan spoke on are classified in the Healthcare sector.
Morgan on recent calls
“With 615 reimbursement approvals, what do you attribute this growth to? Are you seeing more patient ads from the community setting? And then how are you thinking about the path to 60% penetration from here?”
“Following up on one of the previous questions, do you anticipate a similar dynamic will be required in Japan, such that patients will need to be seen by a healthcare practitioner before initiating Vyjuvic?”
Affiliation history
-
Goldman Sachs
Analyst
Transcript header (unverified)
Current